GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hantech Bio-Technology Co Ltd (ROCO:1294) » Definitions » ROE %

Hantech Bio-Technology Co (ROCO:1294) ROE % : 55.40% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Hantech Bio-Technology Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Hantech Bio-Technology Co's annualized net income for the quarter that ended in Dec. 2023 was NT$194.2 Mil. Hantech Bio-Technology Co's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was NT$350.6 Mil. Therefore, Hantech Bio-Technology Co's annualized ROE % for the quarter that ended in Dec. 2023 was 55.40%.

The historical rank and industry rank for Hantech Bio-Technology Co's ROE % or its related term are showing as below:

ROCO:1294' s ROE % Range Over the Past 10 Years
Min: 9.57   Med: 21.5   Max: 49.39
Current: 45.9

During the past 5 years, Hantech Bio-Technology Co's highest ROE % was 49.39%. The lowest was 9.57%. And the median was 21.50%.

ROCO:1294's ROE % is ranked better than
95.95% of 1829 companies
in the Consumer Packaged Goods industry
Industry Median: 6.65 vs ROCO:1294: 45.90

Hantech Bio-Technology Co ROE % Historical Data

The historical data trend for Hantech Bio-Technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hantech Bio-Technology Co ROE % Chart

Hantech Bio-Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
9.57 49.39 20.52 21.50 44.55

Hantech Bio-Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial 13.35 10.18 29.99 35.79 55.40

Competitive Comparison of Hantech Bio-Technology Co's ROE %

For the Packaged Foods subindustry, Hantech Bio-Technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hantech Bio-Technology Co's ROE % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's ROE % falls into.



Hantech Bio-Technology Co ROE % Calculation

Hantech Bio-Technology Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=148.118/( (266.89+398.089)/ 2 )
=148.118/332.4895
=44.55 %

Hantech Bio-Technology Co's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=194.228/( (303.094+398.089)/ 2 )
=194.228/350.5915
=55.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Hantech Bio-Technology Co  (ROCO:1294) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=194.228/350.5915
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(194.228 / 755.664)*(755.664 / 758.99)*(758.99 / 350.5915)
=Net Margin %*Asset Turnover*Equity Multiplier
=25.7 %*0.9956*2.1649
=ROA %*Equity Multiplier
=25.59 %*2.1649
=55.40 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=194.228/350.5915
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (194.228 / 242.394) * (242.394 / 244.488) * (244.488 / 755.664) * (755.664 / 758.99) * (758.99 / 350.5915)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8013 * 0.9914 * 32.35 % * 0.9956 * 2.1649
=55.40 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Hantech Bio-Technology Co ROE % Related Terms

Thank you for viewing the detailed overview of Hantech Bio-Technology Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hantech Bio-Technology Co (ROCO:1294) Business Description

Traded in Other Exchanges
N/A
Address
No. 60, Section 1, Zhongshan Road, Yuanlin, TWN
Hantech Bio-Technology Co Ltd provides health food customization services and most styles of patented aluminum foil bag packaging for Taiwan's health food manufacturers for liquids, jelly, and crystal jelly and others.

Hantech Bio-Technology Co (ROCO:1294) Headlines

No Headlines